Search research articles
Contact Us
Filters
Showing results (171-180 of 191) with videos related to
Page
of 20
Sort By:
Clinical Pharmacokinetics
|
August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
Pierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Thrombosis Research
|
August 23, 2024
Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia
J E Megías-Vericat, S Bonanad Boix, S Haya Guaita, et al.
Cancers
|
April 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
Leukemia & Lymphoma
|
October 6, 2016
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Juan Eduardo Megías-Vericat, Pau Montesinos, María José Herrero, et al.
Alternatives to Laboratory Animals : ATLA
|
August 15, 2009
A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop
Philip Marx-Stoelting, Els Adriaens, Hans-Jürgen Ahr, et al.
Journal of Clinical Apheresis
|
May 8, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, et al.
European Journal of Haematology
|
February 20, 2021
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain
Antonio Solana-Altabella, Blanca Boluda, Rebeca Rodríguez-Veiga, et al.
Annals of Hematology
|
April 29, 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
María P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, et al.
Heliyon
|
February 7, 2024
Silica-coated magnetic particles for efficient RNA extraction for SARS-CoV-2 detection
Natalia Capriotti, Leslie C Amorós Morales, Elisa de Sousa, et al.
Alternatives to Laboratory Animals : ATLA
|
January 18, 2005
Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50
Alessandra Gennari, Christine van den Berghe, Silvia Casati, et al.
Page
of 20
Search research articles
Search
Showing results (171-180 of 191) with videos related to
Sort By:
Page
of 20
Clinical Pharmacokinetics
|
August 23, 2019
Development and Validation of a Population-Pharmacokinetic Model for Rurioctacog Alfa Pegol (Adynovate<sup>®</sup>): A Report on Behalf of the WAPPS-Hemo Investigators Ad Hoc Subgroup
Pierre Chelle, Cindy H T Yeung, Stacy E Croteau, et al.
Thrombosis Research
|
August 23, 2024
Development and testing of a mobile app for systematic collection of patient-reported outcomes (PROs) in patients with hemophilia
J E Megías-Vericat, S Bonanad Boix, S Haya Guaita, et al.
Cancers
|
April 23, 2022
Healthcare Resource Utilization among Patients between 60-75 Years with Secondary Acute Myeloid Leukemia Receiving Intensive Chemotherapy Induction: A Spanish Retrospective Observational Study
Antonio Solana-Altabella, Juan Eduardo Megías-Vericat, Octavio Ballesta-López, et al.
Leukemia & Lymphoma
|
October 6, 2016
Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia
Juan Eduardo Megías-Vericat, Pau Montesinos, María José Herrero, et al.
Alternatives to Laboratory Animals : ATLA
|
August 15, 2009
A review of the implementation of the embryonic stem cell test (EST). The report and recommendations of an ECVAM/ReProTect Workshop
Philip Marx-Stoelting, Els Adriaens, Hans-Jürgen Ahr, et al.
Journal of Clinical Apheresis
|
May 8, 2021
Extracorporeal photopheresis vs standard therapies for steroid-refractory chronic graft-vs-host disease: Pharmacoeconomic assessment of hospital resource use in Spain
Blanca Boluda, Antonio Solana-Altabella, Isabel Cano, et al.
European Journal of Haematology
|
February 20, 2021
Healthcare resource utilization in adult patients with relapsed/refractory FLT3 mutated acute myeloid leukemia: A retrospective chart review from Spain
Antonio Solana-Altabella, Blanca Boluda, Rebeca Rodríguez-Veiga, et al.
Annals of Hematology
|
April 29, 2021
A phase I trial of selinexor plus FLAG-Ida for the treatment of refractory/relapsed adult acute myeloid leukemia patients
María P Martínez Sánchez, Juan Eduardo Megías-Vericat, Rebeca Rodríguez-Veiga, et al.
Heliyon
|
February 7, 2024
Silica-coated magnetic particles for efficient RNA extraction for SARS-CoV-2 detection
Natalia Capriotti, Leslie C Amorós Morales, Elisa de Sousa, et al.
Alternatives to Laboratory Animals : ATLA
|
January 18, 2005
Strategies to replace in vivo acute systemic toxicity testing. The report and recommendations of ECVAM Workshop 50
Alessandra Gennari, Christine van den Berghe, Silvia Casati, et al.
Page
of 20